|
Volumn 19, Issue 3, 2001, Pages 723-744
|
Sexually transmitted diseases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIBIOTIC AGENT;
AZITHROMYCIN;
BENZATHINE PENICILLIN;
CEFOTAXIME;
CEFOTETAN;
CEFOXITIN;
CEFTIZOXIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
CLINDAMYCIN;
DOXYCYCLINE;
FAMCICLOVIR;
GENTAMICIN;
METRONIDAZOLE;
OFLOXACIN;
PROBENECID;
PROCAINE PENICILLIN;
TETRACYCLINE DERIVATIVE;
VALACICLOVIR;
CHLAMYDIA TRACHOMATIS;
CHLAMYDIASIS;
CLINICAL FEATURE;
CLINICAL PRACTICE;
DECISION MAKING;
DIAGNOSTIC PROCEDURE;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
FIRST AID;
GENITAL HERPES;
GONORRHEA;
HEALTH CARE PERSONNEL;
HUMAN;
PATIENT COMPLIANCE;
PATIENT COUNSELING;
PELVIC INFLAMMATORY DISEASE;
PHYSICIAN ATTITUDE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
REVIEW;
SEXUAL BEHAVIOR;
SYPHILIS;
TREATMENT PLANNING;
ULCUS MOLLE;
UNITED STATES;
|
EID: 0034876748
PISSN: 07338627
EISSN: None
Source Type: Journal
DOI: 10.1016/s0733-8627(05)70212-1 Document Type: Review |
Times cited : (6)
|
References (12)
|